Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Athanasios Pseftogas

4PUBLICATIONS

19CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsCancer diagnosis

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Apr 08, 2026

The deubiquitinase activity of CYLD is required for B cell differentiation.

Athanasios Pseftogas, Jessica Bordini, George Gavriilidis

|Mar 18, 2025

Loss of CYLD promotes splenic marginal zone lymphoma.

Athanasios Pseftogas, Jessica Bordini, Silvia Heltai

|Oct 28, 2023

Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency.

Nikolaos Bekas, Martina Samiotaki, Maria Papathanasiou

|Jul 02, 2020

HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice.

Hara Afaloniati, Katerina Angelopoulou, Alexander Giakoustidis

Pageof 1

Frequent Collaborators

2 joint publications

Konstantinos Xanthopoulos

2 joint publications

George Mosialos

2 joint publications

Paolo Ghia

1 joint publications

Hara Afaloniati

1 joint publications

Katerina Angelopoulou

1 joint publications

Alexandros Hardas

1 joint publications

Kali Makedou

1 joint publications

Athanasios Gargavanis

1 joint publications

Theofilos Poutahidis

1 joint publications

Nikolaos Bekas

Frequent Collaborators

2 joint publications

Konstantinos Xanthopoulos

2 joint publications

George Mosialos

2 joint publications

Paolo Ghia

1 joint publications

Hara Afaloniati

Top Related Videos

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay

Published on : Sep 27, 2024

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on : Oct 23, 2019

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on : Jun 03, 2018

See more related videos

Top Related Videos

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay

Published on : Sep 27, 2024

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on : Oct 23, 2019

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on : Jun 03, 2018

See more related videos